ABU-ALI SINA (AVICENNA) AND THE DESCRIPTION OF TRIGEMINAL NEURALGIA

by J. Lotfi
Published 1996-07-01

LONG-TERM CLINICAL OUTCOME IN NORMAL VOLUNTEERS AND PATIENTS WITH CEREBRAL TRANSIENT ISCHEMIC ATTACKS

by J.Lotfi
Published 1999-06-01

ABU-ALI SINA (AVICENNA) AND THE DESCRIPTION OF TRIGEMINAL NEURALGIA

by J. Lotfi
Published 1996-12-01

LONG-TERM CLINICAL OUTCOME IN NORMAL VOLUNTEERS AND PATIENTS WITH CEREBRAL TRANSIENT ISCHEMIC ATTACKS

by J.Lotfi
Published 1999-03-01

COGNITIVE DYSFUNCTION IN MULTIPLE SCLEROSIS: INFLUENCE OF CLINICAL VARIABLES

by J. Lotfi K. Alikhani
Published 1998-06-01

COGNITIVE DYSFUNCTION IN MULTIPLE SCLEROSIS: INFLUENCE OF CLINICAL VARIABLES

by J. Lotfi K. Alikhani
Published 1998-07-01

INCREASED URINARY NEOPTERIN: CREATININE RATIO AS A MARKER OF ACTIVATION OF CELL-MEDIATED IMMUNITY AND OXIDATIVE STRESS IN THE IRANIAN PATIENTS WITH MULTIPLE SCLEROSIS

by H. Khorami, TR. Neyestani, Mehri. Kadkhodaee, J. Lotfi
Published 2003-09-01

ACQUIRED COLOR VISION DEFICIENCY IN PARKINSON’S DISEASE

by S.A. Tabassi, S.G. Sepanlou J. Lotfi
Published 2003-09-01

ACQUIRED COLOR VISION DEFICIENCY IN PARKINSON’S DISEASE

by S.A. Tabassi, S.G. Sepanlou J. Lotfi
Published 2003-07-01

Mesenchymal Stem Cell Therapy for Multiple Sclerosis

by M Mohyeddin Bonab, S Yazdanbakhsh, K Alimoghaddom, A Ghavamzadeh, F Hooshmand, J Lotfi, F Talebian, B Nikbin
Published 2005-06-01